Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 21606412

Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2011 Jul 1
First author
Kurzrock R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 Jul 1;29(19):2616-8. doi: 10.1200/JCO.2010.34.0505.
    note
    Source null
    related pmid
    21606409
    relationship
    Comment in

Authors and identifiers

  1. name
    Kurzrock R
    type
    Author
  2. name
    Sherman SI
    type
    Author
  3. name
    Ball DW
    type
    Author
  4. name
    Forastiere AA
    type
    Author
  5. name
    Cohen RB
    type
    Author
  6. name
    Mehra R
    type
    Author
  7. name
    Pfister DG
    type
    Author
  8. name
    Cohen EE
    type
    Author
  9. name
    Janisch L
    type
    Author
  10. name
    Nauling F
    type
    Author
  11. name
    Hong DS
    type
    Author
  12. name
    Ng CS
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Kurzrock R
    type
    Author
  2. name
    Sherman SI
    type
    Author
  3. name
    Ball DW
    type
    Author
  4. name
    Forastiere AA
    type
    Author
  5. name
    Cohen RB
    type
    Author
  6. name
    Mehra R
    type
    Author
  7. name
    Pfister DG
    type
    Author
  8. name
    Cohen EE
    type
    Author
  9. name
    Janisch L
    type
    Author
  10. name
    Nauling F
    type
    Author
  11. name
    Hong DS
    type
    Author
  12. name
    Ng CS
    type
    Author
bibliography ids
  1. nci-bib-80d7371603773e595edb1dd5
book metadata
content sha256
3d96af30c5e22eb34c867bfe5c8ee4801c0c38aa459344b8a2c4eb732b58c767
document type
citation
dois
  1. 10.1200/JCO.2010.32.4145
electronic publication date
display
2011 May 23
precision
day
year
2011
evidence scope
bibliographic_metadata_only
id
pubmed:21606412
immutable id
pubmed:21606412@3d96af30c5e22eb34c867bfe5c8ee4801c0c38aa459344b8a2c4eb732b58c767
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
19
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2660-6
volume
29
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2011 Jul 1;29(19):2616-8. doi: 10.1200/JCO.2010.34.0505.
    note
    Source null
    related pmid
    21606409
    relationship
    Comment in
outcomes validated
false
pmid
21606412
provenance
batch id
a366a1bc8ed89d8d7ca5
provider
NCBI PubMed ESummary
record sha256
308701f6048d817ee8c2e6d51fff16b2e125f167a9695dfc0a00186fec4467ad
response sha256
c4fde29a469958f2f95ac1ef059ab1994169370e37d8293c0823efce81dabbb8
retrieved at
2026-09-09T23:46:40.540025+00:00
publication date
display
2011 Jul 1
precision
day
year
2011
publication types
  1. Clinical Trial, Phase I
  2. Journal Article
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/21606412/
title
Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer.

Preserved source evidence · Not medical advice